Document Detail


Cerebral interstitial levels of glutamate and glutamine after intravenous administration of nutritional amino acids in neurointensive care patients.
MedLine Citation:
PMID:  15893876     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
After severe trauma or disease glutamine (GLN) is mobilised from all muscles, including the heart and smooth muscles. The result is weakness and fatigue which affects recovery. The breakdown of muscle tissue can be counteracted by external GLN supply. There are concerns, however, that increasing the blood glutamine (Blood-GLN) concentration in patients with acute brain diseases is harmful by elevating the CNS interstitial (IS) concentration of glutamate (CNS-GLT), and that this may result in a secondary excitotoxic injury. We therefore studied the IS CNS-GLN and CNS-GLT when a commercially available nutritional amino acid solution was given intravenously. Ten NICU patients were included. The IS concentrations of amino acids in the brain were measured using intracerebral microdialysis. Blood concentrations of amino acids were measured before and after the amino acid infusion. The change in Blood-GLN was 2.14 (median; range 1.34-3.22) times the basal levels and Blood-GLT increased 1.37 (median; range 0.93-3.45) times basal levels. Both changes were statistically significant. The changes in CNS-GLN was 1.21 (median; range 0.72-1.92) and for CNS-GLT 0.96 (median; range 0.45-1.53) times the basal levels. This was statistically significant for CNS-GLN but not for CNS-GLT. A high initial CNS-GLT (55.3 micromol/l) in one patient increased even further to 84.4 micromol/l after infusion of amino acid solution. We submit that nutritional amino acid solutions can be administrated to some patients with acute brain disease without increasing the CNS-GLT values. However, since BBB function was not quantified in our study, further evaluation of this issue is warranted.
Authors:
Elisabeth Ronne Engström; Lars Hillered; Per Enblad; Torbjörn Karlsson
Related Documents :
1175676 - The effect of yohimbine on the turnover of brain catecholamines and serotonin.
1912466 - Ph-lactate dissociation during anoxic insult: taurine effect.
1975836 - Gene expression of tyrosine hydroxylase in the developing fetal brain.
4045456 - Kinetic constants for blood-brain barrier amino acid transport in conscious rats.
2638916 - Free fatty acids and sterols in human eccrine sweat.
9420186 - Determination of trans fatty acids in cold pressed oils.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Neuroscience letters     Volume:  384     ISSN:  0304-3940     ISO Abbreviation:  Neurosci. Lett.     Publication Date:    2005 Aug 12-19
Date Detail:
Created Date:  2005-06-20     Completed Date:  2005-08-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7600130     Medline TA:  Neurosci Lett     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  7-10     Citation Subset:  IM    
Affiliation:
Department of Neurosurgery, Uppsala University Hospital, 751 85 Uppsala, Sweden. elisabeth.ronne.engstrom@akademiska.se
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Amino Acids / administration & dosage*
Brain Diseases / metabolism*,  therapy
Cerebral Cortex / drug effects*,  metabolism
Extracellular Space / drug effects*,  metabolism
Female
Glutamic Acid / metabolism*
Glutamine / metabolism*
Humans
Infusions, Intravenous / methods
Intensive Care
Male
Microdialysis / methods
Middle Aged
Chemical
Reg. No./Substance:
0/Amino Acids; 56-85-9/Glutamine; 56-86-0/Glutamic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells.
Next Document:  When word category information encounters morphosyntax: an ERP study.